COMMUNIQUÉS West-GlobeNewswire

Wildflower Brands Closes on Private Placement
02/08/2019
VANCOUVER, British Columbia,, Aug. 02, 2019 (GLOBE NEWSWIRE) -- via NetworkWire: Wildflower Brands Inc. (CSE: SUN) (the “Company”) wishes to announce it has received subscriptions for a convertible debenture financing [...]
Predictive Laboratories to Present New Endometriosis Discoveries in Three Presentations at Leading Scientific Conference Focused on Human Infertility
02/08/2019
American Society of Reproductive Medicine selects findings through scientific peer-review process for presentations at the 75th ASRM Scientific Congress & Expo in October SALT LAKE CITY, Aug. 02, 2019 (GLOBE [...]
Autolus Therapeutics to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8
02/08/2019
LONDON, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release [...]
Agile Therapeutics Announces Pricing of $12 Million Underwritten Public Offering of Common Stock
02/08/2019
PRINCETON, N.J., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of 12,631,579 shares of its [...]
Alphatec to Present at the Canaccord Genuity 39th Annual Growth Conference
02/08/2019
CARLSBAD, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine [...]
Shineco, Inc. Announces Strategic Cooperation Agreement for Acquisition to Construct China’s First Industrial Hemp Museum
02/08/2019
BEIJING, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and [...]
Unum Therapeutics to Review Second Quarter 2019 Financial Results on August 12, 2019
02/08/2019
CAMBRIDGE, Mass., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (Nasdaq: UMRX), a biopharmaceutical company focused on developing potentially curative cellular immunotherapies through its ACTR and BOXR [...]
OrthoPediatrics Corp. to Report Second Quarter 2019 Financial Results on August 7, 2019
02/08/2019
Conference Call to Discuss Results on August 8, 2019 at 8:00 a.m. ET WARSAW, Ind., Aug. 02, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing [...]
Obalon Therapeutics Inc. Announces Pricing of $15,000,000 Public Offering
02/08/2019
SAN DIEGO, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics Inc. (Nasdaq: OBLN) (the “Company”) , a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled [...]
GBT Announces New Employment Inducement Grants
02/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on August 1, 2019, the compensation committee of GBT’s board of directors granted [...]
Athenex Provides an Update Regarding the Vasopressin Case
02/08/2019
BUFFALO, N.Y., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
JSC Olainfarm Management Board will review OLMAFARM Ltd. request for an extraordinary shareholders’ meeting
02/08/2019
On 2 August, 2019 JSC Olainfarm has received a request from its largest shareholder OLMAFARM Ltd. to call for a shareholders' meeting. While fully respecting the rights of the largest shareholder of JSC Olainfarm to [...]
Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics
02/08/2019
First in class Zian™ molecule has shown promising pre-clinical results in treating infections caused by multi-resistant bacteria, molds, fungi and viruses NASHVILLE, Tenn., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Harrow [...]
Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, August 7th, 2019
02/08/2019
Conference Call and Webcast To be Held Wednesday, August 7, 2019 4:30 p.m. Eastern Time NEW YORK, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage [...]
Algernon Pharmaceuticals Announces Emoxypine (NP-178), a Top Selling Drug in Russia, as its Lead Drug for Inflammatory Bowel Disease
02/08/2019
VANCOUVER, British Columbia, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development [...]
Momenta Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results
02/08/2019
— Launches adaptive Phase 2/3 study of nipocalimab (M281) in Warm Autoimmune Hemolytic Anemia (wAIHA), the Company’s third study of its FcRn inhibitor; top-line data expected by end of 2021 — — Company receives FDA Fast [...]
Amicus Therapeutics Receives Marketing Authorization for Galafold® (migalastat) for Fabry Disease in Argentina
02/08/2019
First Oral Precision Medicine Approved for People Living with Fabry Disease with an Amenable Mutation in Argentina First Amicus Regulatory Approval in Latin America CRANBURY, N.J., and BUENOS AIRES, Argentina, Aug. 02, [...]
Cronos Group Establishes New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform
02/08/2019
TORONTO, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has entered into a definitive agreement to acquire four of Redwood [...]
Stemline Therapeutics Reports Second Quarter 2019 Financial Results
02/08/2019
Net revenue for ELZONRIS® was $13.0 million for the second quarter Conference call and live webcast scheduled for today at 8:00 AM ET NEW YORK, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML [...]

Pages